Pathway mapping and development of disease-specific biomarkers: Protein-based network biomarkers

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 2, 2015, Pages 297-314

  Chen, Hao ^a   Zhu, Zhitu ^b   Zhu, Yichun ^c   Wang, Jian ^c   Mei, Yunqing ^a   Cheng, Yunfeng ^c  

^a TONGJI UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Diagnostics; Disease; Dynamic network biomarkers; Network biomarkers; Protein protein interactions

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

BIOLOGY; DISEASE COURSE; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

BIOMARKERS; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; HUMANS; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84921719659     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12447     Document Type: Article

References (134)

1. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011; 12: 56-68.
2. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005; 437: 1173-8.
3. Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005; 122: 957-68.
4. Cusick ME, Yu H, Smolyar A, et al. Literature-curated protein interaction datasets. Nat Methods. 2009; 6: 39-46.
5. Chuang HY, Lee E, Liu YT, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007; 3: 140.
6. Jin G, Zhou X, Wang H, et al. The knowledge-integrated network biomarkers discovery for major adverse cardiac events. J Proteome Res. 2008; 7: 4013-21.
7. Chen L, Liu R, Liu ZP, et al. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012; 2: 342.
8. Liu R, Li M, Liu ZP, et al. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep. 2012; 2: 813.
9. Wang X, Liotta L. Clinical bioinformatics: a new emerging science. J Clin Bioinforma. 2011; 1: 1.
10. Wang X. Role of clinical bioinformatics in the development of network-based Biomarkers. J Clin Bioinforma. 2011; 1: 28.
11. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA. 2006; 103: 5923-8.
12. Pawson T, Linding R. Network medicine. FEBS Lett. 2008; 582: 1266-70.
13. Zanzoni A, Soler-Lopez M, Aloy P. A network medicine approach to human disease. FEBS Lett. 2009; 583: 1759-65.
14. Loscalzo J. Systems biology and personalized medicine: a network approach to human disease. Proc Am Thorac Soc. 2011; 8: 196-8.
15. Tuck DP, Kluger HM, Kluger Y. Characterizing disease states from topological properties of transcriptional regulatory networks. BMC Bioinformatics. 2006; 7: 236.
16. Nomura H, Uzawa K, Yamano Y, et al. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. Br J Cancer. 2007; 97: 792-801.
17. Agrawal A, Sinha A, Ahmad T, et al. Maladaptation of critical cellular functions in asthma: bioinformatic analysis. Physiol Genomics. 2009; 40: 1-7.
18. Cho JH, Gelinas R, Wang K, et al. Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med Genomics. 2011; 4: 8.
19. Presson AP, Sobel EM, Papp JC, et al. Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol. 2008; 2: 95.
20. Uetz P, Dong YA, Zeretzke C, et al. Herpesviral protein networks and their interaction with the human proteome. Science. 2006; 311: 239-42.
21. Calderwood MA, Venkatesan K, Xing L, et al. Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci USA. 2007; 104: 7606-11.
22. Chen H, Song Z, Qian M, et al. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med. 2012; 16: 1286-97.
23. Feltes BC, de Faria Poloni J, Bonatto D. The developmental aging and origins of health and disease hypotheses explained by different protein networks. Biogerontology. 2011; 12: 293-308.
24. Chen H, Wang Y, Bai C, et al. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. J Proteomics. 2012; 75: 2835-43.
25. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005; 437: 1032-7.
26. Oti M, Snel B, Huynen MA, et al. Predicting disease genes using protein-protein interactions. J Med Genet. 2006; 43: 691-8.
27. Qiu P, Wang ZJ, Liu KJ, et al. Dependence network modeling for biomarker identification. Bioinformatics. 2007; 23: 198-206.
28. Wu X, Jiang R, Zhang MQ, et al. Network-based global inference of human disease genes. Mol Syst Biol. 2008; 4: 189.
29. Baranzini SE, Galwey NW, Wang J, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet. 2009; 18: 2078-90.
30. Nibbe RK, Markowitz S, Myeroff L, et al. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics. 2009; 8: 827-45.
31. Ortutay C, Vihinen M. Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies. Nucleic Acids Res. 2009; 37: 622-8.
32. Azuaje F, Devaux Y, Wagner DR. Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. BMC Syst Biol. 2010; 4: 60.
33. Nibbe RK, Koyuturk M, Chance MR. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol. 2010; 6: e1000639.
34. Azuaje FJ, Rodius S, Zhang L, et al. Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction. BMC Med Genomics. 2011; 4: 59.
35. Chen L, Xuan J, Riggins RB, et al. Identifying cancer biomarkers by network-constrained support vector machines. BMC Syst Biol. 2011; 5: 161.
36. Frohlich H. Network based consensus gene signatures for biomarker discovery in breast cancer. PLoS ONE. 2011; 6: e25364.
37. Wang YC, Chen BS. A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. BMC Med Genomics. 2011; 4: 2.
38. Ma X, Lee H, Wang L, et al. CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data. Bioinformatics. 2007; 23: 215-21.
39. Lee E, Jung H, Radivojac P, et al. Analysis of AML genes in dysregulated molecular networks. BMC Bioinformatics. 2009; 10(Suppl. 9): S2.
40. Lage K, Karlberg EO, Storling ZM, et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol. 2007; 25: 309-16.
41. Heiser LM, Wang NJ, Talcott CL, et al. Integrated analysis of breast cancer cell lines reveals unique signaling pathways. Genome Biol. 2009; 10: R31.
42. Iliopoulos D, Malizos KN, Oikonomou P, et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE. 2008; 3: e3740.
43. Liu M, Liberzon A, Kong SW, et al. Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet. 2007; 3: e96.
44. Fang X, Netzer M, Baumgartner C, et al. Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer. Cancer Treat Rev. 2013; 39: 77-88.
45. West J, Beck S, Wang X, et al. An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways. Sci Rep. 2013; 3: 1630.
46. Hu X, Zhao D, Strotmann A. Mapping molecular association networks of nervous system diseases via large-scale analysis of published research. PLoS ONE. 2013; 8: e67121.
47. Han JD, Bertin N, Hao T, et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 2004; 430: 88-93.
48. Komurov K, White M. Revealing static and dynamic modular architecture of the eukaryotic protein interaction network. Mol Syst Biol. 2007; 3: 110.
49. Taylor IW, Linding R, Warde-Farley D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol. 2009; 27: 199-204.
50. Zeng T, Sun SY, Wang Y, et al. Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J. 2013; 280: 5682-95.
51. Liu R, Wang X, Aihara K, et al. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev. 2014; 34: 455-78.
52. Achiron A, Grotto I, Balicer R, et al. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol Dis. 2010; 38: 201-9.
53. Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012; 8: 615.
54. Scheffer M, Bascompte J, Brock WA, et al. Early-warning signals for critical transitions. Nature. 2009; 461: 53-9.
55. Zeng T, Zhang CC, Zhang W, et al. Deciphering early development of complex diseases by progressive module network. Methods. 2014; 67: 334-43.
56. Dreze M, Monachello D, Lurin C, et al. High-quality binary interactome mapping. Methods Enzymol. 2010; 470: 281-315.
57. Lemmens I, Lievens S, Tavernier J. Strategies towards high-quality binary protein interactome maps. J Proteomics. 2010; 73: 1415-20.
58. Venkatesan K, Rual JF, Vazquez A, et al. An empirical framework for binary interactome mapping. Nat Methods. 2009; 6: 83-90.
59. Ewing RM, Chu P, Elisma F, et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007; 3: 89.
60. Bader GD, Betel D, Hogue CW. BIND: the biomolecular interaction network database. Nucleic Acids Res. 2003; 31: 248-50.
61. Mewes HW, Frishman D, Guldener U, et al. MIPS: a database for genomes and protein sequences. Nucleic Acids Res. 2002; 30: 31-4.
62. Xenarios I, Salwinski L, Duan XJ, et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 2002; 30: 303-5.
63. Zanzoni A, Montecchi-Palazzi L, Quondam M, et al. MINT: a Molecular INTeraction database. FEBS Lett. 2002; 513: 135-40.
64. Hermjakob H, Montecchi-Palazzi L, Lewington C, et al. IntAct: an open source molecular interaction database. Nucleic Acids Res. 2004; 32: D452-5.
65. Stark C, Breitkreutz BJ, Reguly T, et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006; 34: D535-9.
66. Peri S, Navarro JD, Kristiansen TZ, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 2004; 32: D497-501.
67. von Mering C, Huynen M, Jaeggi D, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31: 258-61.
68. Croft D, O'Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011; 39: D691-7.
69. Paz A, Brownstein Z, Ber Y, et al. SPIKE: a database of highly curated human signaling pathways. Nucleic Acids Res. 2011; 39: D793-9.
70. Persico M, Ceol A, Gavrila C, et al. HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms. BMC Bioinformatics. 2005; 6: S21.
71. Ramani AK, Bunescu RC, Mooney RJ, et al. Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome. Genome Biol. 2005; 6: R40.
72. Martha VS, Liu Z, Guo L, et al. Constructing a robust protein-protein interaction network by integrating multiple public databases. BMC Bioinformatics. 2011; 12(Suppl. 10): S7.
73. Zhang W, Sun F, Jiang R. Integrating multiple protein-protein interaction networks to prioritize disease genes: a Bayesian regression approach. BMC Bioinformatics. 2011; 12: S11.
74. Chaurasia G, Iqbal Y, Hanig C, et al. UniHI: an entry gate to the human protein interactome. Nucleic Acids Res. 2007; 35: D590-4.
75. Chen JY, Mamidipalli S, Huan T. HAPPI: an online database of comprehensive human annotated and predicted protein interactions. BMC Genomics. 2009; 10: S16.
76. Wang YC, Lin C, Chuang MT, et al. Interspecies protein-protein interaction network construction for characterization of host-pathogen interactions: a Candida albicans-zebrafish interaction study. BMC Syst Biol. 2013; 7: 79.
77. Hart GT, Ramani AK, Marcotte EM. How complete are current yeast and human protein-interaction networks? Genome Biol. 2006; 7: 120.
78. Stumpf MP, Thorne T, de Silva E, et al. Estimating the size of the human interactome. Proc Natl Acad Sci USA. 2008; 105: 6959-64.
79. Yu H, Braun P, Yildirim MA, et al. High-quality binary protein interaction map of the yeast interactome network. Science. 2008; 322: 104-10.
80. Schwartz AS, Yu J, Gardenour KR, et al. Cost-effective strategies for completing the interactome. Nat Methods. 2009; 6: 55-61.
81. Isserlin R, Emili A. Nine steps to proteomic wisdom: a practical guide to using protein-protein interaction networks and molecular pathways as a framework for interpreting disease proteomic profiles. Proteomics Clin Appl. 2007; 1: 1156-68.
82. Rho S, You S, Kim Y, et al. From proteomics toward systems biology: integration of different types of proteomics data into network models. BMB Rep. 2008; 41: 184-93.
83. Wang Y, Joshi T, Zhang XS, et al. Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics. 2006; 22: 2413-20.
84. Wang RS, Wang Y, Wu LY, et al. Analysis on multi-domain cooperation for predicting protein-protein interactions. BMC Bioinformatics. 2007; 8: 391.
85. Wang RS, Wang Y, Zhang XS, et al. Inferring transcriptional regulatory networks from high-throughput data. Bioinformatics. 2007; 23: 3056-64.
86. Chen L, Wu LY, Wang Y, et al. Revealing divergent evolution, identifying circular permutations and detecting active-sites by protein structure comparison. BMC Struct Biol. 2006; 6: 18.
87. Zhenping L, Zhang S, Wang Y, et al. Alignment of molecular networks by integer quadratic programming. Bioinformatics. 2007; 23: 1631-9.
88. Li Z, Zhou W, Zhang XS, et al. A parsimonious tree-grow method for haplotype inference. Bioinformatics. 2005; 21: 3475-81.
89. Liu ZP, Wu LY, Wang Y, et al. Prediction of protein-RNA binding sites by a random forest method with combined features. Bioinformatics. 2010; 26: 1616-22.
90. Wang J, Huang Q, Liu ZP, et al. NOA: a novel Network Ontology Analysis method. Nucleic Acids Res. 2011; 39: e87.
91. Zhang B, Li H, Riggins RB, et al. Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics. 2009; 25: 526-32.
92. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9: 559.
93. Li J, Roebuck P, Grunewald S, et al. SurvNet: a web server for identifying network-based biomarkers that most correlate with patient survival data. Nucleic Acids Res. 2012; 40: W123-6.
94. Liu Y, Tennant DA, Zhu Z, et al. DiME: a scalable disease module identification algorithm with application to glioma progression. PLoS ONE. 2014; 9: e86693.
95. Nibbe RK, Chowdhury SA, Koyuturk M, et al. Protein-protein interaction networks and subnetworks in the biology of disease. Wiley Interdiscip Rev Syst Biol Med. 2011; 3: 357-67.
96. Ideker T, Ozier O, Schwikowski B, et al. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics. 2002; 18: S233-40.
97. Guo Z, Wang L, Li Y, et al. Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network. Bioinformatics. 2007; 23: 2121-8.
98. Xue H, Xian B, Dong D, et al. A modular network model of aging. Mol Syst Biol. 2007; 3: 147.
99. Hwang T, Park T. Identification of differentially expressed subnetworks based on multivariate ANOVA. BMC Bioinformatics. 2009; 10: 128.
100. Chowdhury SA, Nibbe RK, Chance MR, et al. Subnetwork state functions define dysregulated subnetworks in cancer. J Comput Biol. 2011; 18: 263-81.
101. Anastassiou D. Computational analysis of the synergy among multiple interacting genes. Mol Syst Biol. 2007; 3: 83.
102. Watkinson J, Wang X, Zheng T, et al. Identification of gene interactions associated with disease from gene expression data using synergy networks. BMC Syst Biol. 2008; 2: 10.
103. Kostka D, Spang R. Finding disease specific alterations in the co-expression of genes. Bioinformatics. 2004; 20: i194-9.
104. Fang G, Kuang R, Pandey G, et al. Subspace differential coexpression analysis: problem definition and a general approach. Pac Symp Biocomput. 2010; 15: 145-56.
105. Zhang B, Tian Y, Jin L, et al. DDN: a caBIG(R) analytical tool for differential network analysis. Bioinformatics. 2011; 27: 1036-8.
106. Lee E, Chuang HY, Kim JW, et al. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008; 4: e1000217.
107. Xu M, Kao MC, Nunez-Iglesias J, et al. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics. 2008; 9: S12.
108. Liu KQ, Liu ZP, Hao JK, et al. Identifying dysregulated pathways in cancers from pathway interaction networks. BMC Bioinformatics. 2012; 13: 126.
109. He D, Liu ZP, Chen L. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics. 2011; 12: 592.
110. Zhan X, Desiderio DM. Signaling pathway networks mined from human pituitary adenoma proteomics data. BMC Med Genomics. 2010; 3: 13.
111. Liu X, Liu ZP, Zhao XM, et al. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc. 2012; 19: 241-8.
112. Zhu Y, Shen X, Pan W. Network-based support vector machine for classification of microarray samples. BMC Bioinformatics. 2009; 10: S21.
113. Lavi O, Dror G, Shamir R. Network-induced classification kernels for gene expression profile analysis. J Comput Biol. 2012; 19: 694-709.
114. Vanunu O, Magger O, Ruppin E, et al. Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol. 2010; 6: e1000641.
115. Chang W, Ma L, Lin L, et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer. 2009; 125: 2844-53.
116. Ben-Hamo R, Efroni S. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies. BMC Syst Biol. 2012; 6: 3.
117. Zhang X, Yang H, Gong B, et al. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol. 2012; 107: 281-8.
118. Lim J, Hao T, Shaw C, et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell. 2006; 125: 801-14.
119. Lin CC, Hsiang JT, Wu CY, et al. Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy. BMC Syst Biol. 2010; 4: 138.
120. Ran J, Li H, Fu J, et al. Construction and analysis of the protein-protein interaction network related to essential hypertension. BMC Syst Biol. 2013; 7: 32.
121. Hwang S, Son SW, Kim SC, et al. A protein interaction network associated with asthma. J Theor Biol. 2008; 252: 722-31.
122. Nacher JC, Keith B, Schwartz JM. Network medicine analysis of chondrocyte proteins towards new treatments of osteoarthritis. Proc Biol Sci. 2014; 281: 20132907.
123. Pan S, Wu D, Teschendorff AE, et al. JAK2-centered interactome hotspot identified by an integrative network algorithm in acute Stanford type A aortic dissection. PLoS ONE. 2014; 9: e89406.
124. Leng T, Liu N, Dai Y, et al. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis. J Proteome Res. 2010; 9: 6207-19.
125. Yu X, Li G, Chen L. Prediction and early diagnosis of complex diseases by edge-network. Bioinformatics. 2014; 30: 852-9.
126. Li S, Wang L, Berman M, et al. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011; 35: 426-40.
127. Liu X, Liu R, Zhao XM, et al. Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers. BMC Med Genomics. 2013; 6: S8.
128. Li M, Zeng T, Liu R, et al. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform. 2014; 15: 229-43.
129. Sorani MD, Ortmann WA, Bierwagen EP, et al. Clinical and biological data integration for biomarker discovery. Drug Discov Today. 2010; 15: 741-8.
130. Baumgartner C, Osl M, Netzer M, et al. Bioinformatic-driven search for metabolic biomarkers in disease. J Clin Bioinforma. 2011; 1: 2.
131. Schwarz E, Leweke FM, Bahn S, et al. Clinical bioinformatics for complex disorders: a schizophrenia case study. BMC Bioinformatics. 2009; 10: S6.
132. Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. 2010; 17: 124-30.
133. Encode Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57-74.
134. Thompson R, Johnston L, Taruscio D, et al. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J Gen Intern Med. 2014; 29: S780-7. Doi:10.1007/s11606-014-2908-8.